These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 10980596)
1. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome. Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596 [TBL] [Abstract][Full Text] [Related]
2. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements. Kouidou S; Malousi A; Maglaveras N Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569 [TBL] [Abstract][Full Text] [Related]
3. Germ-line splicing mutation of the p53 gene in a cancer-prone family. Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311 [TBL] [Abstract][Full Text] [Related]
4. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819 [TBL] [Abstract][Full Text] [Related]
6. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family. Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651 [TBL] [Abstract][Full Text] [Related]
7. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456 [TBL] [Abstract][Full Text] [Related]
9. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743 [TBL] [Abstract][Full Text] [Related]
10. [Germline mutations of the p53 gene]. Frebourg T Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948 [TBL] [Abstract][Full Text] [Related]
11. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Bendig I; Mohr N; Kramer F; Weber BH Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368 [TBL] [Abstract][Full Text] [Related]
13. A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome. Varley JM; McGown G; Thorncroft M; Cochrane S; Morrison P; Woll P; Kelsey AM; Mitchell EL; Boyle J; Birch JM; Evans DG Oncogene; 1996 Jun; 12(11):2437-42. PubMed ID: 8649785 [TBL] [Abstract][Full Text] [Related]
14. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations. Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477 [TBL] [Abstract][Full Text] [Related]
15. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Jolly KW; Malkin D; Douglass EC; Brown TF; Sinclair AE; Look AT Oncogene; 1994 Jan; 9(1):97-102. PubMed ID: 8302608 [TBL] [Abstract][Full Text] [Related]
16. Characterization of germline TP53 splicing mutations and their genetic and functional analysis. Varley JM; Attwooll C; White G; McGown G; Thorncroft M; Kelsey AM; Greaves M; Boyle J; Birch JM Oncogene; 2001 May; 20(21):2647-54. PubMed ID: 11420676 [TBL] [Abstract][Full Text] [Related]
17. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
18. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139 [TBL] [Abstract][Full Text] [Related]
19. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Law JC; Strong LC; Chidambaram A; Ferrell RE Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902 [TBL] [Abstract][Full Text] [Related]